Sale is live|00:00:00
Vinati Organics LtdQ1 FY25

Vinati Organics Ltd

Q1 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • Vinati Organics projects a 20% CAGR in revenue over the next three years.
  • Continued robust growth expected in ATBS driven by volume expansion and rising demand from oil recovery and water treatment.
  • Antioxidants (AO) business to see strong momentum with capacity utilization expected to increase from ~50% to 90% over two years.
  • Butyl phenols anticipated to grow steadily, with FY26 revenue expected between INR800-850 crores from antioxidants alone.
  • VOPL (Veeral Organic) subsidiary aims for ~INR100 crores revenue in FY26, ramping up product commercialization.
  • New products under development (anisole derivatives, 4-MAP, TAA, PTAP) to diversify portfolio and fuel growth.
  • Brownfield expansions for ATBS capacity planned in two phases, with phase 1 operational by June 2025.
  • Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies.

Margin guidance

Category 3
  • Vinati Organics projects a 20% CAGR in revenue over the next 3 years, driven by leadership in ATBS, steady butyl phenol performance, and strong antioxidants growth.
  • EBITDA margins are expected to sustain at 26%-27% over the long term (3 to 5 years), excluding other income.
  • Antioxidants (AO) business revenue grew 70% in FY '25 and is anticipated to continue robust growth in FY '26, supported by new product development.
  • ATBS segment showed 30% growth in FY '25, with continued strong demand and expected double-digit volume growth in FY '26.
  • Revenue from butyl phenols and antioxidants combined is expected to grow from INR600 crores in FY '25 to INR800-850 crores in FY '26.
  • Veeral Organic’s (VOPL) revenue is expected around INR100 crores in FY '26, with capacity utilization improving.
  • Continued investments in capex (~INR360 crores in FY '26) and R&D underpin future growth and operational efficiency.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Vinati Organics Ltd and 1,400+ other companies.

Fundraise plans

  • The transcript does not mention any current or planned fundraising through debt or equity.
  • Capital expenditure (capex) plans for FY '26 are around INR 360 crores, focused on expansion, innovation, and operational efficiency.
  • The company is funding capex primarily through internal accruals, as there is no specific reference to raising funds via equity or debt in the call.
  • No mention of new debt or equity issuance for funding the ongoing ATBS expansion, VOPL capex, or other projects.
  • Management focuses on revenue growth, operational efficiencies, and sustained profitability rather than external fundraising.

Order book

  • The company is currently oversold in the ATBS segment.
  • There is a backlog of pending orders for ATBS.
  • The new capacity coming in Phase 1 of the ATBS expansion is expected to be filled immediately upon commissioning due to the existing order book.
  • Demand remains strong, driven by the oil and gas sector and enhanced oil recovery applications.
  • Overall, the company has good visibility and client commitments for increased capacity.

Capex plans

Yes
  • FY'25 capex was approx INR400 crores, focused on capacity enhancements, new products, and operational scalability including investments in Vinati Organic Products Limited (VOPL).
  • ATBS capacity expansion scheduled for completion by June 2025, increasing capacity by about 25-30% in Phase 1, followed by a second phase a year later. Total Brownfield capex for ATBS expansion budgeted at INR300 crores.
  • VOPL capex total INR500 crores; about INR250 crores done, balance pending. Products including MEHQ, Guaiacol, TAA, PTAP, Anisole, and 4-Methoxy Acetophenone will be commercialized.
  • FY'26 capex marked at approx INR360 crores to continue expansion, innovation, and operational efficiency.
  • Plans for the next leg of capex based on success of 3-4 new products currently in R&D.
  • Focus on vertical and horizontal integration to add products and diversify portfolio.

How does Vinati Organics Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Vinati Organics Ltd
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

Unlock with Pro

Want more stocks like Vinati Organics Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio